HERCULES, CA, Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that Deborah J. Neff has been appointed to its Board of Directors. Ms Neff, a 25-year veteran of healthcare and life sciences industries, is President and Chief Executive Officer of […]
WOBURN, Mass.–PathoGenetix Inc., today announced that the Company received $7.5 million in the second closing of its Series B financing to support the development and commercialization of its Genome Sequence Scanning technology for bacterial strain identification. Along with the $4 million raised in the first closing, announced August 1, 2011, the Series B round totals […]
HUBBARD, Ohio – NanoLogix, an innovator in the rapid detection, identification and antibiotic sensitivity determination of live bacteria announced today third-party results for detecting live Mycobacterium tuberculosis (TB) in a revolutionary time of 4 days with its BNP (BioNanoPore) technology. The advanced culture test results with the NanoLogix BNP technology are at least 500% faster […]
OXFORD, England–Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the appointment of a new finance director. Mr Tim Hall will join the company at the start of 2012 and brings a strong track record in financial management and strategic planning together with a broad […]
SAN DIEGO–Illumina, Inc. today announced that it has appointed Dr. Daniel S. Grosu, M.D., as Vice President and Chief Medical Officer. In this newly created position, Dr. Grosu will play a key role in building Illumina’s diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina’s CLIA-certified clinical laboratory. “Dr. Grosu brings […]
WALTHAM, Mass.–PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its newborn screening laboratory service, PerkinElmer Genetics, has launched a new panel to screen for six Lysosomal Storage Disorders (LSDs) as an addition to its current newborn testing and diagnostics portfolio. The LSD Screening […]
CARLSBAD, Calif. — Life Technologies Corporation today announced that its Applied Biosystems 3500 Dx / 3500xL Dx Genetic Analyzer has been approved by China’s State Food and Drug Administration(SFDA) for diagnostic use in China. The 3500 Dx is a capillary-based Sanger Sequencer intended for use in the analysis of human DNA or RNA for the […]
CARLSBAD, Calif. — Life Technologies Corporation (LIFE) today announced that the company has signed an agreement with GlaxoSmithKline Biologicals S.A. (GSK) to develop a diagnostic to be used as a companion test with a GSK candidate cancer immunotherapy. Specifically, Life will develop a qPCR-based molecular diagnostic assay for GSK’s MAGE-A3 cancer immunotherapy candidate designed to […]
Los Angeles, Calif. and Hopkinton, Mass. — DxTerity Diagnostics, Inc. and Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that the companies have entered into a co-development and co-marketing strategic collaboration that will allow researchers to perform DxTerity’s NEATmultiplex diagnostic assays on Caliper’s LabChip Dx instrument platform minimizing sample processing time without compromising data quality. […]
Gaithersburg, Maryland and SEOUL, Korea – Seegene, the world’s leading developer of multiplex molecular diagnostics (M-MoDx), today announced the commercialization of its second real-time assay based upon its new TOCE™ technology. The Anyplex™ II RV16 Detection Assay will provide clinicians with a powerful new tool to help prevent the spread of respiratory infections. The Anyplex […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
